Gemcitabine 25021-0239
Product NDC
25021-0239- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 15, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA209077
Need to source Gemcitabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gemcitabine Hydrochloride | 38 mg/mL |
Drug Class
Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(3)
1 VIAL in 1 CARTON (25021-239-05) / 5.26 mL in 1 VIAL
1 VIAL in 1 CARTON (25021-239-26) / 26.3 mL in 1 VIAL
1 VIAL in 1 CARTON (25021-239-52) / 52.6 mL in 1 VIAL